Aspen Pharmacare (APNHY) Stock Statistics & Valuation Metrics

Aspen Pharmacare has a market cap or net worth of $2.94B. The enterprise value is ―.

Aspen Pharmacare has 446,252,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aspen Pharmacare’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.28%.

The current PE Ratio of Aspen Pharmacare is 22.73. Aspen Pharmacare’s PEG ratio is -1.88.

In the last 12 months, Aspen Pharmacare had revenue of 44.71B and earned 4.40B in profits. Earnings per share was 9.91.

In the last 12 months, operating cash flow was 7.45B and capital expenditures -3.86B, giving a free cash flow of 3.59B billion.

Aspen Pharmacare pays an annual dividend of $0.2, resulting in a dividend yield of 3.01%

Aspen Pharmacare upcoming earnings date is Sep 3, 2025, TBA (Confirmed).

Aspen Pharmacare as a current ratio of 1.81, with Debt / Equity ratio of 42.96%

In the past 12 months, Aspen Pharmacare has paid 1.31B in taxes.

Aspen Pharmacare EV to EBITDA ratio is 12.54, with an EV/FCF ratio of 180.04.

Aspen Pharmacare has $12.34B in cash and marketable securities with Rs36.46B in debt, giving a net cash position of $24.12B billion.

Gross margin is 43.43%, with operating margin of 15.65%, and net profit margin of 9.85%.

The average price target for Aspen Pharmacare is ―, which is 11.43% higher than the current price. The consensus rating is ―